Study explores how nanoplastics could affect child’s immune system during pregnancy

Allergies and asthma are widespread diseases that could arise during embryonal development in the womb.

All selected drugmakers agree to second round of price negotiations under the IRA

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

March 18, 2025

Covid deaths plummet in England, but dementia and heart disease remain a concern

New Government figures show a higher than average number of deaths last month. Dementia was the biggest killer in England and heart disease in Wales.

July 1, 2023

Palleon and Henlius agree on autoimmune therapy development

The partnership focuses on sialidase enzyme therapeutics in conjunction with Henlius’ rituximab. Credit: Jarun Ontakrai/Shutterstock. Palleon Pharmaceuticals and Shanghai Henlius Biotech have entered a licence

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.